These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12135970)

  • 41. Switching schizophrenia patients from typical neuroleptics to olanzapine: effects on BOLD response during attention and working memory.
    Schlagenhauf F; Wüstenberg T; Schmack K; Dinges M; Wrase J; Koslowski M; Kienast T; Bauer M; Gallinat J; Juckel G; Heinz A
    Eur Neuropsychopharmacol; 2008 Aug; 18(8):589-99. PubMed ID: 18554874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abnormal prefrontal cortical activity and connectivity during response selection in first episode psychosis, chronic schizophrenia, and unaffected siblings of individuals with schizophrenia.
    Woodward ND; Waldie B; Rogers B; Tibbo P; Seres P; Purdon SE
    Schizophr Res; 2009 Apr; 109(1-3):182-90. PubMed ID: 19179050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Schizophrenic patients treated with clozapine or olanzapine perform better on theory of mind tasks than those treated with risperidone or typical antipsychotic medications.
    Savina I; Beninger RJ
    Schizophr Res; 2007 Aug; 94(1-3):128-38. PubMed ID: 17560766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neural correlates of recognition memory of social information in people with schizophrenia.
    Harvey PO; Lepage M
    J Psychiatry Neurosci; 2014 Mar; 39(2):97-109. PubMed ID: 24119792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antipsychotic drug effects on motor activation measured by functional magnetic resonance imaging in schizophrenic patients.
    Braus DF; Ende G; Weber-Fahr W; Sartorius A; Krier A; Hubrich-Ungureanu P; Ruf M; Stuck S; Henn FA
    Schizophr Res; 1999 Aug; 39(1):19-29. PubMed ID: 10480664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A dilemma born of progress: switching from clozapine to a newer antipsychotic.
    Rafal S; Tsuang MT; Carpenter WT
    Am J Psychiatry; 1999 Jul; 156(7):1086-90. PubMed ID: 10401457
    [No Abstract]   [Full Text] [Related]  

  • 47. Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation.
    Schlagenhauf F; Dinges M; Beck A; Wüstenberg T; Friedel E; Dembler T; Sarkar R; Wrase J; Gallinat J; Juckel G; Heinz A
    Schizophr Res; 2010 May; 118(1-3):189-200. PubMed ID: 20189356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional lateralization of the sensorimotor cortex in patients with schizophrenia: effects of treatment with olanzapine.
    Bertolino A; Blasi G; Caforio G; Latorre V; De Candia M; Rubino V; Callicott JH; Mattay VS; Bellomo A; Scarabino T; Weinberger DR; Nardini M
    Biol Psychiatry; 2004 Aug; 56(3):190-7. PubMed ID: 15271588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Olanzapine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Use of novel agents in the treatment of schizophrenia and a look to the future].
    Keks NA
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Jun; 18(3):97-101. PubMed ID: 9800201
    [No Abstract]   [Full Text] [Related]  

  • 51. Olanzapine for schizophrenia.
    Duggan L; Fenton M; Dardennes RM; El-Dosoky A; Indran S
    Cochrane Database Syst Rev; 2000; (2):CD001359. PubMed ID: 10796640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tc-99 HMPAO SPECT study of regional cerebral blood flow in olanzapine-treated schizophrenic patients.
    Gonul AS; Kula M; Sofuoglu S; Tutus A; Esel E
    Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):29-33. PubMed ID: 12664310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Canadian multicenter trial assessing memory and executive functions in patients with schizophrenia spectrum disorders treated with olanzapine.
    Stip E; Remington GJ; Dursun SM; Reiss JP; Rotstein E; MacEwan GW; Chokka PR; Jones B; Dickson RA;
    J Clin Psychopharmacol; 2003 Aug; 23(4):400-4. PubMed ID: 12920417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
    Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA
    Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia.
    Ascher-Svanum H; Zhu B; Faries D; Landbloom R; Swartz M; Swanson J
    BMC Psychiatry; 2006 Feb; 6():8. PubMed ID: 16504026
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory task.
    Karch S; Leicht G; Giegling I; Lutz J; Kunz J; Buselmeier M; Hey P; Spörl A; Jäger L; Meindl T; Pogarell O; Möller HJ; Hegerl U; Rujescu D; Mulert C
    J Psychiatr Res; 2009 Oct; 43(15):1185-94. PubMed ID: 19426993
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of alcohol dependence on social brain function.
    Gizewski ER; Müller BW; Scherbaum N; Lieb B; Forsting M; Wiltfang J; Leygraf N; Schiffer B
    Addict Biol; 2013 Jan; 18(1):109-20. PubMed ID: 22340281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
    Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
    Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disturbed functional connectivity within brain networks subserving domain-specific subcomponents of working memory in schizophrenia: relation to performance and clinical symptoms.
    Henseler I; Falkai P; Gruber O
    J Psychiatr Res; 2010 Apr; 44(6):364-72. PubMed ID: 19837416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of olanzapine: an overview of pivotal clinical trials.
    Beasley CM; Tollefson GD; Tran PV
    J Clin Psychiatry; 1997; 58 Suppl 10():7-12. PubMed ID: 9265910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.